期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Dynamics of neutralizing antibody responses to SARS-CoV-2 in patients with COVID-19: an observational study 被引量:1
1
作者 Xin Xu Sheng Nie +11 位作者 Yanqun Wang Quanxin Long Hong Zhu Xiaoyong Zhang Jian Sun qinglang zeng Jincun Zhao Li Liu Ling Li Ailong Huang Jinlin Hou Fan Fan Hou 《Signal Transduction and Targeted Therapy》 SCIE CSCD 2021年第6期1869-1875,共7页
Our understanding of the protective immunity,particularly the long-term dynamics of neutralizing antibody(NAbs)response to SARS-CoV-2,is currently limited.We enrolled a cohort of 545 COVID-19 patients from Hubei,China... Our understanding of the protective immunity,particularly the long-term dynamics of neutralizing antibody(NAbs)response to SARS-CoV-2,is currently limited.We enrolled a cohort of 545 COVID-19 patients from Hubei,China,who were followed up up to 7 months,and determined the dynamics of NAbs to SARS-CoV-2 by using a surrogate virus neutralization test(sVNT).In our validation study,sVNT IC50 titers and the neutralization rate measured at a single dilution(1:20)were well correlated with FRNT titers(r=0.85 and 0.84,respectively).The median time to seroconversion of NAbs was 5.5 days post onset of symptoms.The rate of positive sVNT was 52% in the first week,reached 100% in the third week,and remained above 97% till 6 months post onset.Quantitatively,NAbs peaked in the fourth week and only a quarter of patients had an estimated peak titer of>1000.NAbs declined with a half-time of 61 days(95%CI:49-80 days)within the first two months,and the decay deaccelerated to a half-time of 104 days(95%CI:86-130 days)afterward.The peak levels of NAbs were positively associated with severity of COVID-19 and age,while negatively associated with serum albumin levels.The observation that the low-moderate peak neutralizing activity and fast decay of NAbs in most naturally infected individuals called for caution in evaluating the feasibility of antibody-based therapy and vaccine durability.NAbs response positively correlated with disease severity,warning for the possibility of repeat infection in patients with mild COVID-19. 展开更多
关键词 PATIENTS protective IMMUNITY
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部